Finch Therapeutics Group, Inc.
Case Number:
1:26-bk-10409
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
March 25, 2026
Meet The Attys In Biotech Biz Finch's Ch. 11
A team of attorneys from Chipman Brown Cicero & Cole LLP and Ropes & Gray LLP is steering the Chapter 11 case of Finch Therapeutics, a company that develops treatments to improve the health of the body's microbiome.
-
March 25, 2026
Fecal Treatment Co. Says Ch. 11 Is Best Option To Sell Assets
Microbiome treatment developer Finch Therapeutics told a Delaware bankruptcy judge Wednesday that its lack of income or ability to collect on a patent judgment justified its Chapter 11 filing despite a lack of secured debts.
-
March 24, 2026
Catching Up With New Bankruptcy Case Action
The maker of spandex is looking to swap its debt for equity in Chapter 11, a longtime book distributor plans to finish winding down operations while its bankruptcy keeps an automatic stay on litigation, and a microbiome treatment developer wants to sell its assets in bankruptcy.
-
March 23, 2026
Fecal Treatment Co. Files Ch. 11 To Escape Lease, Sell IP
A company that develops treatments to improve the health of the body's microbiome sought Chapter 11 protection, saying it had never generated a positive cash flow and faces unresolved litigation and a burdensome lease.